Central Cancer Registry Reporting Content IG
1.0.0 - STU 1 United States of America flag

Central Cancer Registry Reporting Content IG, published by HL7 International / Public Health. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-central-cancer-registry-reporting-ig/ and changes regularly. See the Directory of published versions

: Cancer Related Medication Administration - Example - TTL Representation

Raw ttl | Download


@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix sct: <http://snomed.info/id/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

 a fhir:MedicationAdministration ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "cancer-related-medication-administration-example"] ; # 
  fhir:meta [
    ( fhir:profile [
fhir:v "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-administration"^^xsd:anyURI ;
fhir:link <http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-administration>     ] )
  ] ; # 
  fhir:text [
fhir:status [ fhir:v "extensions" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Narrative</b></p><p><b>status:</b> completed</p><p><b>category:</b> Outpatient</p><p><b>medication:</b> rxnorm 1790099 doxorubicin hydrochloride 20 MG per 10 ML Injection</p><p><b>subject:</b> Amy Shaw</p><p><b>effective:</b> 2018-04-22</p><p><b>Performer:</b> Joseph Nichols</p><p><b>reasonReference:</b> Condition-primary-cancer-condition-breast</p><p><b>authoredOn:</b> 2018-04-12</p><p><b>note:</b> doxorubicin (60 mg/m² IV), 105.96 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects.</p><p><b>Route:</b> SNOMED 47625008 Intravenous route (qualifier value)</p><p><b>Dose:</b> 105.96 mg</p></div>"
  ] ; # 
  fhir:status [ fhir:v "completed"] ; # 
  fhir:category [
    ( fhir:coding [
fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/medication-admin-category"^^xsd:anyURI ] ;
fhir:code [ fhir:v "outpatient" ]     ] )
  ] ; # 
  fhir:medication [
a fhir:CodeableConcept ;
    ( fhir:coding [
fhir:system [ fhir:v "http://www.nlm.nih.gov/research/umls/rxnorm"^^xsd:anyURI ] ;
fhir:code [ fhir:v "1790099" ] ;
fhir:display [ fhir:v "10 ML doxorubicin hydrochloride 2 MG/ML Injection" ]     ] )
  ] ; # 
  fhir:subject [
fhir:reference [ fhir:v "Patient/example" ]
  ] ; # 
  fhir:effective [ fhir:v "2018-04-22"^^xsd:date] ; # 
  fhir:performer ( [
fhir:actor [
fhir:reference [ fhir:v "Practitioner/1" ]     ]
  ] ) ; # 
  fhir:reasonReference ( [
fhir:reference [ fhir:v "Condition/primary-cancer-condition-breast" ]
  ] ) ; # 
  fhir:note ( [
fhir:author [
a fhir:Reference ;
fhir:reference [ fhir:v "Practitioner/1" ]     ] ;
fhir:time [ fhir:v "2018-04-22"^^xsd:date ] ;
fhir:text [ fhir:v "doxorubicin (60 mg/m² IV), 105.96 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects." ]
  ] ) ; # 
  fhir:dosage [
fhir:route [
      ( fhir:coding [
a sct:47625008 ;
fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ;
fhir:code [ fhir:v "47625008" ] ;
fhir:display [ fhir:v "Intravenous route (qualifier value)" ]       ] )     ] ;
fhir:dose [
fhir:value [ fhir:v "105.96"^^xsd:decimal ] ;
fhir:unit [ fhir:v "mg" ] ;
fhir:system [ fhir:v "http://unitsofmeasure.org"^^xsd:anyURI ] ;
fhir:code [ fhir:v "mg" ]     ]
  ] . #